Kovitz Investment Group Partners’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.3M | Buy |
18,321
+4,105
| +29% | +$516K | 0.01% | 601 |
|
|
2025
Q1 | $1.95M | Buy |
14,216
+10,318
| +265% | +$1.41M | 0.01% | 586 |
|
|
2024
Q4 | $596K | Sell |
3,898
-1,372
| -26% | -$210K | ﹤0.01% | 844 |
|
|
2024
Q3 | $800K | Buy |
5,270
+1,638
| +45% | +$249K | 0.01% | 674 |
|
|
2024
Q2 | $842K | Buy |
3,632
+1,805
| +99% | +$418K | 0.01% | 570 |
|
|
2024
Q1 | $394K | Buy |
+1,827
| New | +$394K | 0.01% | 542 |
|
|
2022
Q1 | – | Sell |
-15,868
| Closed | -$3.89M | – | 415 |
|
|
2021
Q4 | $3.89M | Buy |
15,868
+276
| +2% | +$67.6K | 0.09% | 148 |
|
|
2021
Q3 | $4.41M | Sell |
15,592
-27
| -0.2% | -$7.64K | 0.09% | 161 |
|
|
2021
Q2 | $5.41M | Sell |
15,619
-438
| -3% | -$152K | 0.11% | 141 |
|
|
2021
Q1 | $4.49M | Buy |
16,057
+189
| +1% | +$52.9K | 0.1% | 142 |
|
|
2020
Q4 | $3.89M | Sell |
15,868
-1,103
| -6% | -$270K | 0.09% | 145 |
|
|
2020
Q3 | $4.81M | Sell |
16,971
-204
| -1% | -$57.9K | 0.13% | 113 |
|
|
2020
Q2 | $4.6M | Sell |
17,175
-583
| -3% | -$156K | 0.14% | 108 |
|
|
2020
Q1 | $5.62M | Sell |
17,758
-666
| -4% | -$211K | 0.2% | 81 |
|
|
2019
Q4 | $5.47M | Buy |
18,424
+185
| +1% | +$54.9K | 0.16% | 96 |
|
|
2019
Q3 | $4.25M | Sell |
18,239
-493
| -3% | -$115K | 0.14% | 123 |
|
|
2019
Q2 | $4.38M | Buy |
18,732
+76
| +0.4% | +$17.8K | 0.14% | 112 |
|
|
2019
Q1 | $4.41M | Buy |
18,656
+167
| +0.9% | +$39.5K | 0.14% | 109 |
|
|
2018
Q4 | $5.56M | Buy |
+18,489
| New | +$5.56M | 0.22% | 71 |
|